DB
APTO

Danske Bank’s Aptose Biosciences, Inc. APTO Stock Holding History

Danske Bank’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4
Closed -$13 – 1602
2025
Q1 		$13 Buy
+4
New +$19 ﹤0.01% 1314

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
GG
Gleason Group Prospect, Kentucky $1.15B AUM 21.11% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return

Danske Bank's APTO Position: Q2 2025 in Review

Danske Bank sold out of Aptose Biosciences, Inc. (APTO) in Q2 2025, closing a stake of 4 shares — an estimated $13 sold.

Danske Bank first reported a position in APTO in Q1 2025 and held it in 1 quarter. The position peaked at $13 in Q1 2025. 4 funds tracked by Wall St. Rank hold APTO as of Q2 2025.

  • Danske Bank reported no remaining Aptose Biosciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • Danske Bank sold 4 Aptose Biosciences, Inc. shares in Q2 2025, an estimated $13.
  • Danske Bank first reported a position in Aptose Biosciences, Inc. in Q1 2025 and held it in 1 quarter.
  • Danske Bank's Aptose Biosciences, Inc. position peaked at $13 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2025.

Based on Danske Bank's 13F filing for Q2 2025, filed 18 Dec 2025.